TIDMNCYT

RNS Number : 8579F

Novacyt S.A.

13 July 2023

Novacyt S.A.

("Novacyt", the "Company" or the "Group")

Notice of cancelled AGM

New AGM to be held by the end of October 2023

Paris, France and Eastleigh, UK - 13 July 2023 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company's Annual General Meeting (AGM), due to take place on 10 August 2023 has been cancelled and will be held by the end of October.

In the absence of a quorum at the AGM convened for 15 June 2023, a second meeting was planned for 10 August 2023. Following the recent announcement concerning the recommended cash offer for Yourgene Health plc and following consent from the French court to delay approval of the FY2022 Accounts until 31 October 2023, the Company now intends to hold an AGM later in 2023 enabling as many shareholders as possible to attend, which is not possible during the summer months.

Forms of Proxy already received will unfortunately be void and full details of the new AGM and dates concerning voting will follow in due course.

Contacts

 
 Novacyt SA                                                          +44 (0)23 8074 8830 
 James Wakefield, Non-Executive 
  Chairman 
  James McCarthy, Acting Chief Executive 
  Officer 
 
 SP Angel Corporate Finance LLP (Nominated 
  Adviser and Broker)                                                +44 (0)20 3470 0470 
 Matthew Johnson / Charlie Bouverat (Corporate 
  Finance) 
  Vadim Alexandre / Rob Rees (Corporate Broking) 
 
 Numis (Joint Broker)                                                +44 (0)20 7260 1000 
 Freddie Barnfield / Duncan Monteith / Jack 
  McLaren 
 
 Allegra Finance (French Listing Sponsor)                            +33 (1) 42 22 10 10 
  Rémi Durgetto / Yannick Petit                       r.durgetto@allegrafinance.com 
                                                            / y.petit@allegrafinance.com 
 
 Walbrook PR (Financial PR & IR)                                     +44 (0)20 7933 8780 
  Stephanie Cuthbert / Anna Dunphy                                novacyt@walbrookpr.com 
  / Phillip Marriage

About Novacyt Group

Novacyt is an international diagnostics business delivering a broad portfolio of in vitro and molecular diagnostic tests for a wide range of infectious diseases, enabling faster, more accurate, accessible testing to improve healthcare outcomes. The Company provides customers with a seamless sample-to-result workflow using its integrated and scalable instrumentation/solutions. The Company specialises in the design, manufacture, and supply of real-time PCR kits, reagents and a full range of laboratory and qPCR instrumentation for molecular biology research and clinical use. Novacyt offers one of the world's most varied and comprehensive range of qPCR assays, covering human, veterinary, biodefence, environmental, agriculture and food testing.

Novacyt is headquartered in Vélizy in France with offices in Stokesley and Eastleigh, UK, and is listed on the London Stock Exchange's AIM market ("NCYT") and on the Paris Stock Exchange Euronext Growth ("ALNOV").

For more information, please refer to the website: www.novacyt.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCKLLFFXDLXBBZ

(END) Dow Jones Newswires

July 13, 2023 02:00 ET (06:00 GMT)

Novacyt (LSE:NCYT)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Novacyt.
Novacyt (LSE:NCYT)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Novacyt.